EpiCept to Report Second Quarter 2011 Operating Highlights and Financial Results on August 15, 2011
August 09, 2011 17:01 ET
|
Immune Pharmaceuticals Inc
EpiCept to Report Second Quarter 2011 Operating Highlights and Financial
Results on August 15, 2011
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept...
EpiCept Corporation Announces Publication in Journal Blood of a New Meta-Analysis Examining Lack of Efficacy of Interleukin-2 ....
July 18, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept Corporation Announces Publication in Journal Blood of a New
Meta-Analysis Examining Lack of Efficacy of Interleukin-2 ....
Meta-Analysis of Six International Randomized AML Trials Clearly...
EpiCept Corporation Announces Reconvened Stockholders' Meeting Results
June 28, 2011 18:07 ET
|
Immune Pharmaceuticals Inc
EpiCept Corporation Announces Reconvened Stockholders' Meeting Results
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq...
EpiCept Receives Initial FDA Comments on Application for Ceplene® Special Protocol Assessment
June 27, 2011 00:19 ET
|
Immune Pharmaceuticals Inc
EpiCept Receives Initial FDA Comments on Application for Ceplene®
Special Protocol Assessment
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept...
EpiCept Announces Webcast of Annual Shareholder Meeting
June 22, 2011 18:02 ET
|
Immune Pharmaceuticals Inc
EpiCept Announces Webcast of Annual Shareholder Meeting
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm...
EpiCept Seeks Primary Listing Status on OMX Stockholm Exchange
June 22, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept Seeks Primary Listing Status on OMX Stockholm Exchange
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX...
EpiCept Corporation Announces Stockholders' Meeting Results and Adjournment
June 20, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept Corporation Announces Stockholders' Meeting Results and
Adjournment
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and...
EpiCept Announces Resignation of Board Member
June 16, 2011 21:00 ET
|
Immune Pharmaceuticals Inc
EpiCept Announces Resignation of Board Member
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange:...
EpiCept to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
June 13, 2011 17:05 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at the 5th Lippert/Heilshorn Life Sciences & Medical
Technologies Virtual Conference on June 16
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory...
EpiCept Receives Positive Nasdaq Panel Decision
June 07, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept Receives Positive Nasdaq Panel Decision
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange:...